Challenges and Opportunities in Using Residual Newborn Screening Samples for Translational Research: Workshop Summary

Parent Collection
The National Academies Press: Proceedings and Other Reports
Authoring Institution
Institute of Medicine
Publisher
National Academies Press
Year
2010
Rights
Use of Materials on the OEC
Discipline(s)
Life and Environmental Sciences
Research Ethics
Topics
Conflict of Interest
Emerging Technologies
Human Rights
Human Subjects Research
Privacy and Surveillance
Public Well-being
Responsible Innovation
Security
Social Responsibility
Vulnerable Populations
Expert Reports
Body

Newborn screening samples are used to test more than 4 million infants each year for life-threatening diseases that are treatable if found at birth. These specimens also represent a potentially invaluable resource for public health and biomedical research. The IOM held a workshop to examine issues surrounding the use of residual specimens for translational research.

Read Challenges and Opportunities in Using Residual Newborn Screening Samples for Translational Research: Workshop Summary.